Ftse Mib
36.613,47
0,50%
DAX
21.751,08
0,09%
S&P 500
6.071,17
0,53%
NASDAQ
19.681,75
0,25%
Bitcoin
104.030,90
-0,67%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ LivaNova PLC (LIVN) LivaNova PLC (LIVN) Notizie

LivaNova PLC

LIVN
50,64
0,00 (0,00%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202515:00BWLivaNova to Announce Fourth-Quarter and Full-Year 2024..
17/1/202522:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/1/202515:00BWLivaNova Appoints Natalia Kozmina as Chief Human Resources..
18/12/202414:30BWRECOVER Clinical Study Shows Meaningful Benefits of..
17/12/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:40EDGAR2Form 144 - Report of proposed sale of securities
10/12/202423:30EDGAR2Form 144 - Report of proposed sale of securities
05/12/202415:00BWLivaNova to Present Scientific Data at American Epilepsy..
14/11/202415:00BWLivaNova to Present at the Stifel, Wolfe, and Piper Sandler..
11/11/202422:05BWLivaNova Announces OSPREY Clinical Study Meets Primary..
01/11/202422:12EDGAR2Form 8-K - Current report
30/10/202411:03EDGAR2Form 8-K - Current report
30/10/202411:00BWLivaNova Reports Third-Quarter 2024 Results
15/10/202413:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/10/202415:02EDGAR2Form 8-K - Current report
08/10/202415:00BWLivaNova Appoints Susan Podlogar as a New Director
25/9/202415:00BWLivaNova to Announce Third-Quarter 2024 Results
17/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202422:02EDGAR2Form 3/A - Initial statement of beneficial ownership of..
13/9/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202422:58EDGAR2Form 144 - Report of proposed sale of securities
10/9/202415:01EDGAR2Form 8-K - Current report
19/8/202415:00BWLivaNova to Present at the Baird Global Healthcare..
09/8/202422:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/8/202422:25EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
01/8/202422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202412:01EDGAR2Form 8-K - Current report
31/7/202412:00BWLivaNova Reports Second-Quarter 2024 Results
18/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202415:00BWLivaNova to Announce Second-Quarter 2024 Results
12/6/202422:12EDGAR2Form 8-K - Current report
06/6/202415:00BWLivaNova Provides Update on RECOVER Clinical Study..
23/5/202415:00BWLivaNova to Present at the Goldman Sachs Healthcare..
17/5/202422:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/5/202412:00BWLivaNova Reports First-Quarter 2024 Results
30/4/202415:00BWLivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation..
25/4/202422:03BWLivaNova Issues Notice to U.S. Patients Regarding..
21/3/202414:00BWLivaNova to Announce First-Quarter 2024 Results
20/3/202414:00BWLivaNova Announces a Positive Predictive Outcome of Trial..
11/3/202421:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202403:55EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 50,64

La tua Cronologia

NASDAQ
LIVN
LivaNova
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci